Santa Clara, California, USA: Cold chain shipping container supplier Invensify and Senpex, a provider of last-mile deliveries have partnered to improve delivery of temperature-sensitive pharmaceuticals.
The collaboration will see Senpex incorporate Invensify’s Insuridge shipping containers into its logistics.
The Insuridge temperature-controlled shipping container, pictured, is an alternative to passive shippers that rely on dry ice or phase-change materials. By using semiconductor technology, the Insuridge container ensures the protection of temperature-sensitive materials such as DNA, RNA, intact cells, pharmaceuticals during transport.
“We are thrilled to partner with Senpex and provide them with our cutting-edge Insuridge shipping containers,” said Faizan Ahmed, chief executive, Invensify.
“Our solution aligns perfectly with Senpex’s commitment to embracing advanced technologies and improving the reliability of their courier services. Together, we are transforming the last-mile delivery of temperature-sensitive pharmaceuticals, ensuring the integrity and safety of these critical products.”
Anar Mammadov, chief executive, Senpex Technology, said: Partnering with Invensify to provide FDA 21 CFR compliant tracking and monitoring of temperature-sensitive pharmaceutical shipments was a natural decision. We believe this collaboration will significantly contribute to our mission of delivering affordable, convenient, and trusted shipping services to industries of all sizes.”
